{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:05:34Z","timestamp":1790701534893,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.retram.2026.103605","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:08:00Z","timestamp":1788278880000},"page":"103605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of bone marrow fibrosis on disease characteristics and outcomes in newly diagnosed multiple myeloma patients"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5665-7599","authenticated-orcid":false,"given":"Ali","family":"Ahadzade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugrul","family":"Elverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Kucukyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkadir","family":"Ercaliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahu Senem","family":"Demir\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Emre","family":"Eskazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhlis Cem","family":"Ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y\u0131ld\u0131z","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Salihoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2026.103605_bib0001","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.retram.2026.103605_bib0002","doi-asserted-by":"crossref","first-page":"60698","DOI":"10.18632\/oncotarget.10849","article-title":"Microenvironment drug resistance in multiple myeloma: emerging new players","volume":"7","author":"Di Marzo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.retram.2026.103605_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/183602","article-title":"Multiple myeloma macrophages: pivotal players in the tumor microenvironment","volume":"2013","author":"Berardi","year":"2013","journal-title":"J Oncol"},{"key":"10.1016\/j.retram.2026.103605_bib0004","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imr.12233","article-title":"Targeting the bone marrow microenvironment in multiple myeloma","volume":"263","author":"Kawano","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.retram.2026.103605_bib0005","first-page":"1","article-title":"Immunological dysregulation in multiple myeloma microenvironment","volume":"2014","author":"Romano","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.retram.2026.103605_bib0006","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ajcp\/87.3.342","article-title":"Histologic classification and staging of multiple myeloma: a retrospective and prospective study of 674 cases","volume":"87","author":"Bartl","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.retram.2026.103605_bib0007","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10517-017-3645-x","article-title":"Incidence of myelofibrosis in chronic myeloid leukemia, multiple myeloma, and chronic lymphoid leukemia during various phases of diseases","volume":"162","author":"Dolgikh","year":"2017","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.retram.2026.103605_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/0019-509X.48594","article-title":"Prognostic significance of bone marrow histology in multiple myeloma","volume":"46","author":"Subramanian","year":"2009","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.retram.2026.103605_bib0009","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1002\/cam4.3265","article-title":"The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and\/or proteasome inhibitors","volume":"9","author":"Paul","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.retram.2026.103605_bib0010","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.e19514","article-title":"The presence of bone marrow fibrosis is associated with poorer prognosis in newly diagnosed multiple myeloma treated with immunomodulatory agents and\/or proteasome inhibitors","volume":"37","author":"Paul","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.retram.2026.103605_bib0011","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2026.103605_bib0012","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00000478-199703000-00011","article-title":"Risk Groups of Myeloma Patients by Histologic Pattern and Proliferative Activity","volume":"21","author":"Pich","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.retram.2026.103605_bib0013","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.retram.2026.103605_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188988","article-title":"Immunoparesis in newly diagnosed Multiple Myeloma patients: effects on overall survival and progression free survival in the Danish population","volume":"12","author":"S\u00f8rrig","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.retram.2026.103605_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","volume":"12","author":"Blad\u00e9","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.retram.2026.103605_bib0016","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41409-024-02336-w","article-title":"Correction: harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.retram.2026.103605_bib0017","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/his.12871","article-title":"Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study","volume":"68","author":"Kvasnicka","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.retram.2026.103605_bib0018","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12185-025-03958-6","article-title":"Extramedullary disease in multiple myeloma at diagnosis and over the course of the disease","volume":"122","author":"Guliyev","year":"2025","journal-title":"Int J Hematol"},{"key":"10.1016\/j.retram.2026.103605_bib0019","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12185-022-03373-1","article-title":"Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary disease","volume":"116","author":"Koshiishi","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.retram.2026.103605_bib0020","doi-asserted-by":"crossref","DOI":"10.1097\/01.HS9.0000970660.09840.e4","article-title":"P939: The relationship of bone marrow fibrosis with extramedullary disease in multiple myeloma","volume":"7","author":"Konyaoglu","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.retram.2026.103605_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13000-024-01516-y","article-title":"Bone marrow fibrosis in newly diagnosed multiple myeloma and its correlation with clinicopathological factors","volume":"19","author":"Hu","year":"2024","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.retram.2026.103605_bib0022","first-page":"109","article-title":"Assessment of bone marrow biopsy and cytogenetic findings in patients with multiple myeloma","volume":"39","author":"\u015eeyhanl\u0131","year":"2022","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.retram.2026.103605_bib0023","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5045\/br.2022.2022033","article-title":"Update on primary plasma cell leukemia","volume":"57","author":"Jung","year":"2022","journal-title":"Blood Res"},{"key":"10.1016\/j.retram.2026.103605_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01497","article-title":"Case report: concomitant diagnosis of plasma cell leukemia in patient with jak2 positive myeloproliferative neoplasm","volume":"10","author":"Kurian","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.retram.2026.103605_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1363","article-title":"Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients","volume":"8","author":"Hamdaoui","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.retram.2026.103605_bib0026","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/cells10061360","article-title":"Role of 1q21 in multiple myeloma: from pathogenesis to possible therapeutic targets","volume":"10","author":"Burroughs Garc\u00eca","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.retram.2026.103605_bib0027","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10245330512331390140","article-title":"Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27 Kip1 and an aggressive clinical course in multiple myeloma","volume":"10","author":"Shaughnessy","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.retram.2026.103605_bib0028","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","article-title":"Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the international myeloma working group","volume":"127","author":"Sonneveld","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.retram.2026.103605_bib0029","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.clml.2025.06.003","article-title":"SOHO State of the Art Updates and Next Questions | Late\/Deferred ASCT in Myeloma","volume":"25","author":"Mo","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.retram.2026.103605_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/scrt54","article-title":"Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment","volume":"2","author":"Hoggatt","year":"2011","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.retram.2026.103605_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5462087","article-title":"Prognostic significance of blood transfusion in newly diagnosed multiple myeloma patients without autologous hematopoietic stem cell transplantation","volume":"2017","author":"Fan","year":"2017","journal-title":"Biomed Res Int"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:30:38Z","timestamp":1790699438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318626000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2452318626000413"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2026.103605","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of bone marrow fibrosis on disease characteristics and outcomes in newly diagnosed multiple myeloma patients","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2026.103605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103605"}}